DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
Attention
Tuesday, August 11, 2009
New Bone Drug Can Cut Fracture Risk In Elderly
Two studies suggest treatment works better than current medications
A first-of-its-kind osteoporosis drug lowers the risk of bone fractures as well as or better than current medicines, studies in older women and men with prostate cancer suggest.
Advisers to the Food and Drug Administration will review those studies and other data on the safety and effectiveness of Amgen Inc.'s denosumab Thursday, then recommend whether the agency should approve the genetically engineered drug.
Wall Street sees it as a potential blockbuster crucial to Amgen's future. But given the crowded market of treatments for the bone-thinning disease, doctors see its expected high cost as a big drawback.
GO HERE to read more.
Subscribe to:
Post Comments (Atom)
2 comments:
This is socialism.
more drugs for fix......preventative medicine people. Milky does the body good.
Post a Comment